Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

APG-1387

APG-1387, a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP) . APG-1387 induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. APG-1387 can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma.

Product Specifications

CAS Number

1570231-89-8

Purity

>98% (HPLC)

Solubility

DMSO : 50 mg/mL (43.20 mM; Need ultrasonic)

Smiles

O=S (C1=CC=CC (S (=O) (N (C[C@@H]2NC ([C@@H] (NC) C) =O) CC[C@] (CC[C@H]3C (NC (C4=CC=CC=C4) C5=CC=CC=C5) =O) ([H]) N3C2=O) =O) =C1) (N (C[C@@H]6NC ([C@@H] (NC) C) =O) CC[C@] (CC[C@H]7C (NC (C8=CC=CC=C8) C9=CC=CC=C9) =O) ([H]) N7C6=O) =O

Molecular Formula

C??H??N??O??S?

Molecular Weight

1157.4

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

5- (2-nitrophenyl) thiophene-2-carbaldehyde
sc-277861 250 mg

5- (2-nitrophenyl) thiophene-2-carbaldehyde

Sign In for Pricing
View Details
Mak16 3'UTR Lenti-reporter-Luc Vector
27967086 1.0 µg

Mak16 3'UTR Lenti-reporter-Luc Vector

Sign In for Pricing
View Details
Recombinant Lymphocyte Activation Gene 3 (LAG3)
MBS2125497-01 0.01 mg

Recombinant Lymphocyte Activation Gene 3 (LAG3)

Sign In for Pricing
View Details
Recombinant Lymphocyte Activation Gene 3 (LAG3)
MBS2125497-02 0.05 mg

Recombinant Lymphocyte Activation Gene 3 (LAG3)

Sign In for Pricing
View Details
Recombinant Lymphocyte Activation Gene 3 (LAG3)
MBS2125497-03 0.1 mg

Recombinant Lymphocyte Activation Gene 3 (LAG3)

Sign In for Pricing
View Details
Recombinant Lymphocyte Activation Gene 3 (LAG3)
MBS2125497-04 0.2 mg

Recombinant Lymphocyte Activation Gene 3 (LAG3)

Sign In for Pricing
View Details